Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Blood Specimen Collection × 1 year × Clear all

Sponsor

Conditions

Neoplasms 37 Breast Neoplasms 37 Lung Neoplasms 21 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Prostatic Neoplasms 13 Uterine Cervical Neoplasms 10 Head and Neck Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 9 Sarcoma 8 Ovarian Neoplasms 8 Myelodysplastic Syndromes 8 Melanoma 8 Multiple Myeloma 7 Glioma 7 Colonic Neoplasms 7 Brain Neoplasms 7 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Disease 6 Neoplastic Cells, Circulating 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Gastrointestinal Neoplasms 5 Uveal Melanoma 4 Skin Neoplasms 4 Neoplasm, Residual 4 Lymphoma, Non-Hodgkin 4

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡